先前的研究策略大多通过多肽模拟再感染事件来实现局部癌症免疫治疗，但其疗效通常受到多肽表位长度的限制。随着mRNA技术在新冠疫苗研发中取得突破性进展，基于mRNA的疗法展现出靶点丰富、安全性高、研发周期短等优势。因此，利用mRNA技术重启机体的免疫 ...

President Donald Trump signed an executive order on artificial intelligence Thursday that will revoke past government ...

Public health experts say there could be massive implications after President Trump signed an executive order withdrawing the ...

The company’s latest RSV vaccine is yet to show promising sales. This has weighed on MRNA stock, down 52% since early 2024. Even if we look at a slightly longer period, the changes in MRNA stock ...

The Details of Moderna's Award HHS reported that it had provided the drug maker with the funds in order "to accelerate the development of mRNA-based pandemic influenza vaccines and enhance (its ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...